ssa retatrutide – San Antonio Peptides (ARL) Retatrutide Long-Term Safety: What Happens

doi: 10.1172/jci72434 13 MulJDBeggDPBarreraJGLiBMatterEKD'AlessioDAet al

Data from a large retrospective cohort study to be presented at the 2026 American Society of Clinical Oncology (ASCO) Breakthrough Meeting showed that GLP-1 receptor agonist (GLP-1 RA) use was significantly associated with lower colorectal cancer incidence among patients with inflammatory bowel disease (IBD), including those with comorbid type 2 diabetes (T2D)

Do Not Self-Adjust Medication It can be tempting to reduce your levothyroxine dose yourself if you see a "normal" result while losing weight

Similarly, in the SYNERGY-NASH study (Table 3), improvement of at least one fibrosis stage without worsening of MASH was almost doubled with tirzepatide treatment than with placebo [5]